News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Frontage Labs

Advertisement

Articles by Frontage Labs

Twenty Years of Growth

ByFrontage Labs
July 15th 2021

Learn how Frontage Laboratories started, recent growth and expansion, and the future vision of Frontage

Twenty Years of Growth at Frontage Labs

ByFrontage Labs
July 15th 2021
Advertisement

Latest Updated Articles

  • Twenty Years of Growth
    Twenty Years of Growth

    Published: July 15th 2021 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications

2

Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million

3

FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices

4

Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences

5

Taming the Complexity of CGT Commercialization: 5 Keys to a Workable Operating Model

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us